Subscribe
AEC Quarterly
No Result
View All Result
  • Big Story
  • Opinion
  • Energy
  • Interviews
  • Africa
  • Investment
  • Big Story
  • Opinion
  • Energy
  • Interviews
  • Africa
  • Investment
No Result
View All Result
AEC Quarterly
No Result
View All Result

South Africa calls off AstraZeneca vaccine roll-out

2 years ago
Reading Time: 2 mins read
South Africa calls off AstraZeneca vaccine roll-out

A vaccine trial volunteer

South Africa on Sunday suspended plans to inoculate its front-line health care workers with the Oxford-AstraZeneca vaccine after a clinical trial suggested that it isn’t effective in preventing mild to moderate illness from the variant dominant in the country.

The country received its first one million doses of the AstraZeneca vaccine last week and was expected to begin giving jabs to health care workers in the middle of this month.

But preliminary data from a small study suggested that the AstraZeneca vaccine offers only “minimal protection against mild-moderate disease” caused by the variant in South Africa.

Related articles

Cholera Outbreak hits 23 states in Nigeria

Guinean President Alpha Condé deposed in military coup

The study, which hasn’t yet been peer-reviewed, involved 2,000 people, most of whom were young and healthy. The volunteers’ average age was 31.

Salim Abdool Karim, chairman of South Africa’s COVID-19 advisory committee, said there wasn’t enough data on how well the vaccine protects against severe disease caused by the variant.

“The AstraZeneca vaccine rollout needs to be put on temporary hold while we get the clinical efficacy information,” he said.

He added that there would only be a wide scale rollout of the jab if new data on could show “acceptable” hospitalization rates.

Other vaccines have shown reduced efficacy against the variant, but have provided good protection from serious disease and death.

Health minister Zweli Mkhize said discussions were being held to explore available alternatives.

“There are discussions going on on Sputnik, Sputnik V. There are discussions going on about Sinopharm, the department and the ministerial advising committee are dealing with that. There are discussions that are going on with Moderna. And we will also need to explore Novavax, that one there had not been much of discussion. So the discussion on all of them remains open”, said Mkhize.

Source: africanews
Tags: AstraZenecaSouth Africa
Share122Tweet76Share31
Previous Post

DR Congo’s Félix Tshisekedi emerges African Union Chairman

Next Post

5 Young African Entrepreneurs to look out for in 2021

Related Posts

cholera outbreak in Nigeria
Africa

Cholera Outbreak hits 23 states in Nigeria

September 7, 2021
President Alpha Condé
Africa

Guinean President Alpha Condé deposed in military coup

September 6, 2021
First malaria vaccine rollout commences in Africa
Africa

Groundbreaking Malaria Vaccine is ready for use

September 3, 2021
Zamfara kidnapping crisis
Latest News

Zamfara shuts down schools completely after mass abduction of students

September 3, 2021
Vaccination in Uganda
Covid-19

State of COVID-19 in Uganda

August 30, 2021
South Sudan President and rival
Africa

South Sudan Leaders propose merge of Rival Armed Forces

August 30, 2021

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Post

  • 5 Young African Entrepreneurs to look out for in 2021

    5 Young African Entrepreneurs to look out for in 2021

    317 shares
    Share 127 Tweet 79
  • Meet Cira-O3, Egypt’s COVID-19 Robot Nurse

    313 shares
    Share 125 Tweet 78
  • Winning in the African Oil and Gas Industry

    312 shares
    Share 125 Tweet 78
  • Africa claims Top 3 spots for the Highest Concentration of Women Entrepreneurs in the World

    312 shares
    Share 125 Tweet 78
  • Assessing Africa’s Digital Response Strategy to COVID-19

    311 shares
    Share 124 Tweet 78

Recommended

Ebola outbreak in Guinea

Scientists say recent Guinean Ebola outbreak may have been sparked by someone infected 5 years ago

March 22, 2021
South Africa acquires vaccine

COVID-19: South Africa acquires 20 Million Vaccine doses

January 21, 2021

Sign Up For AEC Quarterly Newsletter

Get our most compelling stories delivered straight to your inbox.

AEC Quarterly

AEC Quarterly is a great read for investors looking for new opportunities with articles and reports exploring growth, creativity and entrepreneurial spirit.

  • Big Story
  • Africa
  • Opinion
  • Energy
  • Finance
  • Interviews
  • Home
  • About
  • Contact
  • Get Featured in AEC Quarterly Magazine

© 2020 AEC Quarterly. All Rights Reserved. Use of this site constitutes acceptance of our, Terms of Use and Privacy Policy.

No Result
View All Result
  • Big Story
  • Opinion
  • Energy
  • Interviews
  • Africa
  • Investment

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Go to mobile version